David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEAC
3226
DELISTED
Seachange International Inc
SEAC
| $339K | ﹤0.01% |
+2,162
| New | +$317K |
|
|
CEL
3227
DELISTED
Cellcom Israel, Ltd.
CEL
| $339K | ﹤0.01% |
70,665
+53,159
| +304% | +$304K |
|
|
PPL
3228
CALL
PPL Corp
PPL
$26.3B
| $337K | ﹤0.01% |
10,737
-52,716
| -83% | -$1.69M |
|
|
ARPI
3229
DELISTED
AMERICAN RESIDENTIAL PPTYS INC COM
ARPI
| $335K | ﹤0.01% |
18,630
+7,495
| +67% | +$133K |
|
|
TRK
3230
DELISTED
Speedway Motorsports, Inc.
TRK
| $334K | ﹤0.01% |
+14,689
| New | +$332K |
|
|
KANG
3231
DELISTED
iKang Healthcare Group, Inc.
KANG
| $334K | ﹤0.01% |
20,590
+990
| +5% | +$16.5K |
|
|
CJES
3232
PUT
DELISTED
C&J ENERGY SVCS LTD
CJES
| $334K | ﹤0.01% |
30,000
| – | – |
|
3233
Marcus Corp
MCS
$930M
| $332K | ﹤0.01% |
15,596
-4,181
| -21% | -$81K |
|
3234
Universal Display
OLED
$4.11B
| $332K | ﹤0.01% |
7,105
-9,010
| -56% | -$320K |
|
|
EXPR
3235
PUT
DELISTED
Express, Inc.
EXPR
| $331K | ﹤0.01% |
1,000
-2,000
| -67% | -$579K |
|
|
BAS
3236
DELISTED
Basis Energy Services, Inc.
BAS
| $330K | ﹤0.01% |
84
-503
| -86% | -$1.89M |
|
|
REXX
3237
DELISTED
Rex Energy Corporation
REXX
| $329K | ﹤0.01% |
8,839
-29,201
| -77% | -$1.2M |
|
|
TAT
3238
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $328K | ﹤0.01% |
61,387
+3,695
| +6% | +$17.8K |
|
3239
STMicroelectronics
STM
$44.1B
| $326K | ﹤0.01% |
+35,196
| New | +$307K |
|
|
CA
3240
PUT
DELISTED
CA, Inc.
CA
| $326K | ﹤0.01% |
10,000
-59,000
| -86% | -$1.87M |
|
3241
HealthEquity
HQY
$8.81B
| $325K | ﹤0.01% |
+13,020
| New | +$282K |
|
3242
RBC Bearings
RBC
$15.7B
| $324K | ﹤0.01% |
+4,235
| New | +$266K |
|
|
KAMN
3243
DELISTED
Kaman Corp
KAMN
| $323K | ﹤0.01% |
+7,610
| New | +$305K |
|
3244
Ennis
EBF
$543M
| $321K | ﹤0.01% |
22,702
+4,305
| +23% | +$58.6K |
|
|
BRDR
3245
DELISTED
BODERFREE INC COM
BRDR
| $321K | ﹤0.01% |
53,449
+36,583
| +217% | +$253K |
|
3246
Agilysys
AGYS
$3.23B
| $320K | ﹤0.01% |
32,503
+2,655
| +9% | +$27.6K |
|
|
SCHW
3247
CALL
Charles Schwab
SCHW
$194B
| $320K | ﹤0.01% |
10,500
-47,700
| -82% | -$1.38M |
|
|
TAL
3248
CALL
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $318K | ﹤0.01% |
7,800
-2,200
| -22% | -$91.2K |
|
3249
ATI
ATI
$29.3B
| $317K | ﹤0.01% |
10,549
-132,913
| -93% | -$4.13M |
|
3250
CorVel
CRVL
$3.54B
| $317K | ﹤0.01% |
+27,678
| New | +$323K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.